Last mentioned: Mar 18, 2026
Earnings Release
VitalHub and dLocal report Q4 2025 financial results, exceeding growth expectations.
Market Low
ATB Cormark cuts VitalHub price target to C$15.00 as stock hits 1-year low.
AI Deployment
VitalHub announces AI-enhanced referral management deployment with Novari Health.
dLocal and VitalHub reported strong fourth-quarter 2025 results, highlighting robust demand for cross-border payment solutions and healthcare SaaS. VitalHub notably achieved a 35% increase in Annual Recurring Revenue (ARR), while dLocal continues to scale its footprint in high-growth emerging markets.
VitalHub reported a 52% surge in Q4 2025 revenue to $31.4 million, while dLocal's latest financial results highlight continued expansion in the high-growth fintech sector. These reports come just days after VitalHub hit a 1-year low, suggesting a potential fundamental turnaround for specialized SaaS and payment providers.
VitalHub reported a 52% surge in total revenue for Q4 2025, driven by a 35% increase in Annual Recurring Revenue (ARR) to $96.1 million. Simultaneously, dLocal's latest financial results highlight the growing demand for cross-border payment solutions in emerging markets, including the expanding digital health sector.